Approval

Kerala Ayurveda Limited receives US patent for its herbal formulation

 The United States Patent and Trademark Office (USPTO) has granted KAL its first patent for a proprietary herbal formulation that…

2 years ago

Sputnik V vaccine granted full permanent approval in Russia

Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries…

3 years ago

Biophore receives sub-license from MPP to manufacture and market molnupiravir for COVID treatment

Can market in India and 104 other countries Has also received DCGI regulatory license for Indian market Licenses applicable for…

3 years ago

LumiraDx Receives Approval for its COVID-19 Antigen Test for use in India

London, October 30, 2021:  Test combines sensitivity with speed and is designed to be used in health care settings to…

3 years ago

Roche Receives Approval for Laboratory Based Elecsys SARS-CoV-2 Antigen Test to Facilitate High-Volume Testing in the Country

Mumbai, June 08, 2021:  The Elecsys SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the…

3 years ago

Lupin Launches Zileuton Extended-Release Tablets

Mumbai, August 11, 2020: Pharma major Lupin Limited (Lupin) announced the launch of Zileuton Extended-Release Tablets, 600 mg, having received…

4 years ago

Lupin Receives Tentative Approval for Empagliflozin Tablets

Mumbai, August 04, 2020: Pharma major Lupin Limited (Lupin) announced that it has received tentative approval for its Empagliflozin Tablets, 10…

4 years ago

Lupin Receives Tentative Approval for Empagliflozin and Linagliptin Tablets

Mumbai, July 23 2020: Pharma major Lupin Limited (Lupin) announced that it has received tentative approval for its Empagliflozin and…

4 years ago

Baxter India gets CDSCO Nod for Oxiris Filter to Treat COVID-19 Patients

New Delhi, July 08, 2020: Baxter India has received approval from the Central Drugs Standard Control Organization (CDSCO) under Directorate General…

4 years ago

Lupin and Mylan Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept

Mumbai, June 04, 2020: Lupin Limited (Lupin) and Mylan N.V. (NASDAQ: MYL) today announced that the European Commission (EC) has…

4 years ago